Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study.
Tani C, Cardelli C, Moroni L, Zen M, Bottazzi F, Fredi M, Bortoluzzi A, Piga M, Riccio F, Ceccarelli F, De Marchi G, Manfredi L, Mulè R, Biancalana E, Gatto M, Coladonato L, Conigliaro P, Gerosa M, Diamanti AP, Ramirez GA, Vesentini F, Zanframundo G, Orlandi C, Silvagni E, Chessa E, Trevisani M, Palmerini M, Pilo PFG, Ferrigno S, Di Lollo AC, Noviello S, Lo Gullo A, De Andres MI, Guiducci S, Emmi G, Maiolini F, De Angelis R, Caporali RF, Iannone F, Moroncini G, Quartuccio L, Conti F, Ciccia F, Govoni M, Franceschini F, Cavagna L, Iaccarino L, Dagna L, Mosca M.
Tani C, et al. Among authors: coladonato l.
Lancet Rheumatol. 2026 Mar;8(3):e181-e191. doi: 10.1016/S2665-9913(25)00316-9. Epub 2026 Feb 5.
Lancet Rheumatol. 2026.
PMID: 41655581